MADRID — New data from two randomized trials suggest that dual antiplatelet therapy (DAPT) should be significantly shortened or not used at all after coronary artery bypass surgery (CABG). Researchers ...
MADRID, Spain—Adding ticagrelor on top of aspirin alone for 1 year does not lower the incidence of death, MI, stroke, or repeat revascularization in ACS patients who undergo CABG surgery, according to ...
Addition of the PCSK9 inhibitor evolocumab to statin therapy after cardiac bypass surgery did not improve 24-month graft patency in the NEWTON-CABG CardioLink-5 trial. Subodh Verma, MD, cardiac ...
MADRID, Spain—Adding evolocumab (Repatha; Amgen) to statin therapy does not lower the risk of saphenous vein graft (SVG) failure among patients who undergo coronary artery bypass surgery, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results